Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.42 USD | +0.71% | +2.90% | +5.97% |
04-24 | Precigen, Inc. to Present Late-Breaking Abstract for Pivotal Phase 2 Study Data for PRGN- 2012 AdenoVerse Immunotherapy | CI |
03-25 | North American Morning Briefing : Tech in Focus on -2- | DJ |
- Stock Market
- Equities
- PGEN Stock
- News Precigen, Inc.